Clayton Lau
Overview
Explore the profile of Clayton Lau including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
1307
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang X, Ma S, Twardowski P, Lau C, Chan Y, Wong K, et al.
Clin Transl Med
. 2024 Oct;
14(10):e70048.
PMID: 39390760
Background: In a previously reported Phase I trial, we observed therapy-associated declines in circulating myeloid-derived suppressor cells (MDSCs) with the administration of white button mushroom (WBM) tablets in prostate cancer...
2.
Cabrera Chien L, Sun C, Kim H, Uranga C, Soto-Perez-de-Celis E, Burhenn P, et al.
J Geriatr Oncol
. 2024 Sep;
16(1):102063.
PMID: 39271412
No abstract available.
3.
Andrade G, Lau C, Olivares R, Duarte I, Teles S, Gavassa F, et al.
Urology
. 2024 Jun;
192:44-51.
PMID: 38945486
Objective: To describe the trocar disposition, docking angles, surgical times, functional outcomes, and complications experienced during the first 30 surgeries with Hugo RAS platform performed by a high-volume Da Vinci...
4.
Cui Z, Ma R, Yang C, Malpani A, Chu T, Ghazi A, et al.
NPJ Digit Med
. 2024 Jun;
7(1):152.
PMID: 38862627
Suturing skill scores have demonstrated strong predictive capabilities for patient functional recovery. The suturing can be broken down into several substep components, including needle repositioning, needle entry angle, etc. Artificial...
5.
Motzer R, Jonasch E, Agarwal N, Alva A, Bagshaw H, Baine M, et al.
J Natl Compr Canc Netw
. 2024 Feb;
22(1):4-16.
PMID: 38394781
The NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for diagnostic workup, staging, and treatment of patients with renal cell carcinoma (RCC). These NCCN Guidelines Insights focus on the systemic...
6.
Cerrato C, Meagher M, Autorino R, Simone G, Yang B, Uzzo R, et al.
Minerva Urol Nephrol
. 2023 Aug;
75(4):425-433.
PMID: 37530659
Background: Utility of partial nephrectomy (PN) for complex renal mass (CRM) is controversial. We determined the impact of surgical modality on postoperative renal functional outcomes for CRM. Methods: We retrospectively...
7.
Melstrom L, Kaiser A, Lau C, Chan K, Raoof M, Singh G, et al.
Am Surg
. 2023 Jul;
89(11):5027-5029.
PMID: 37503832
No abstract available.
8.
Chu T, Wong E, Ma R, Yang C, Dalieh I, Hui A, et al.
Eur Urol Focus
. 2023 Jun;
9(6):1044-1051.
PMID: 37277274
Background: Virtual reality (VR) simulators are increasingly being used for surgical skills training. It is unclear what skills are best improved via VR, translate to live surgical skills, and influence...
9.
Lee K, Lindenfeld L, Echevarria M, Hsu J, Wong F, Narayan H, et al.
Int J Cardiol
. 2023 Mar;
380:40-46.
PMID: 36958393
Background: Tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs) have revolutionized the treatment of metastatic renal cell carcinoma (mRCC). Emerging data suggest that these agents can result in clinically...
10.
Cerrato C, Patel D, Autorino R, Simone G, Yang B, Uzzo R, et al.
World J Urol
. 2023 Mar;
41(3):747-755.
PMID: 36856832
Purpose: To compare outcomes of robotic-assisted partial nephrectomy (RAPN) and minimally invasive radical nephrectomy (MIS-RN) for complex renal masses (CRM). Methods: We conducted a retrospective multicenter analysis of CRM patients...